Prostate cancer collaborative stage data items-their definitions, quality, usage, and clinical implications: A review of SEER data for 2004-2010

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

(2013) Ahmedin Jemal et al.   JNCI-Journal of the National Cancer Institute

Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling and Specimen Processing

(2013) Marc A. Bjurlin et al.   JOURNAL OF UROLOGY

A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer

(2012) Scott E. Eggener et al.   JOURNAL OF UROLOGY

Gleason grading: past, present and future

(2011) Brett Delahunt et al.   HISTOPATHOLOGY

SEER Coding Standards Result in Underestimation of Positive Surgical Margin Incidence at Radical Prostatectomy: Results of a Systematic Audit

(2011) Satyan K. Shah et al.   JOURNAL OF UROLOGY

Prostate Specific Antigen Best Practice Statement: 2009 Update

(2009) Kirsten L. Greene et al.   JOURNAL OF UROLOGY

Changes in Gleason Score Grading and Their Effect in Predicting Outcome After Radical Prostatectomy

(2009) Matvey Tsivian et al.   UROLOGY

Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy

(2008) Stephen A. Boorjian et al.   JOURNAL OF UROLOGY

Combined Prostate-specific Antigen Density and Biopsy Features to Predict “Clinically Insignificant” Prostate Cancer

(2008) Stacy Loeb et al.   UROLOGY